from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2579/dhaA

LFCtreatmentdescriptionclass of inhibitor

0.372

Amikacinug/mL Amikacintranslation

0.501

Cap5-10ug/mL Capreomycintranslation

0.674

Rox10-50 ug/mL Roxithromycintranslation

0.112

SM2-5 ug/mL Streptomycintranslation

0.682

Tet5-10 ug/mL Tetracyclinetranslation

1.105

Rif0.2-5ug/mL Rifampicintranscription

0.588

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.948

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.807

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.301

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.836

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.481

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.825

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.608

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.289

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.874

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.338

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.552

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.559

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.636

KCN5-20 ug/mL Potassium cyaniderespiration

0.536

NaN30.2-2 mM Sodium aziderespiration

-0.041

Nigericin50 uM Nigericinrespiration

-0.575

TRC10-150 ug/mL Triclosanrespiration

-0.596

TRZ10-25 ug/mL Thioridazinerespiration

-1.705

Valinomycin0.5-10 uM Valinomycinrespiration

1.388

ZnSO42 mM ZnSO4respiration

-0.644

menadione6-10 ug/mL Menadionerespiration

-0.480

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.285

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.367

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.118

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.438

NRP_1Non-replicating persistence stage 1dosRassociated

-0.432

Amp0.2mg/mL AmpicillincellWall

-0.361

Cephalexin20-100 ug/mL CephalexincellWall

0.086

Cerulenin0.32-5 ug/mL CerulenincellWall

0.056

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.159

EMB10-20 ug/mL EthambutolcellWall

0.078

Eta12-40 ug/mL EthionamidecellWall

-0.267

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.218

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.508

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.203

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.098

BZA0.12 mg/mL BenzamidearomaticAmides

0.068

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.596

H2O24 mM hydrogen peroxideDNAdamaging

0.836

Levo10 ug/mL LevofloxacinDNAdamaging

1.052

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.758

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.516

Oflox5-10 ug/mL OfloxacinDNAdamaging

2.241

UVUV-irradiationDNAdamaging

0.092

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.136

Antimycin12.5-50 ug/mL Antimycin A?

-0.100

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.071

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.088

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.693

PA8240.2-2 ug/mL PA-824?

-0.882

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.352

Verapamil50 uM Verapamil?

-0.441

mercaptoethanol2 mM 2-Mercaptoethanol?

0.386

methoxatin10-20 ug/mL Methoxatin?